Latest News and Press Releases

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...

Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Notification of Transactions of Persons Discharging Managerial Responsibilities Oxford, UK, and Cambridge, MA, US, 15 January 2020...

Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection Oxford, UK, and Cambridge, MA, US, 7 January 2020...

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are...

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...

Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Completion of $50 million Subscription and Placing and Directorate Changes Oxford, UK, and Cambridge, MA, US, 24 December 2019 -...

Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Award of Share Options Oxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new...

Summit Therapeutics plc  (‘Summit’ or the ’Company’) Exercise of Restricted Stock Units Oxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM)...

Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Result of General Meeting, Admission of Fundraising Shares and Directorate Changes Oxford, UK, and Cambridge, MA, US, 23 December 2019...